Latest Press Release on cancer

EntreMed's ENMD-2076 Active in Solid and Hematological Cancers
ROCKVILLE, Md., Nov. 16 -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the presentation of data for the Phase 1 study for its Aurora A/angiogenic kinase inhibitor, E...

---

Seattle Cancer Care Alliance Radiology Director Responds to New Mammography Screening Recommendations
SEATTLE, Nov. 16 /PRNewswire/ -- The following is a statement by Constance Lehman, M.D., PhD, medical director of radiology and director of breast imaging, Seattle Cancer Care Alliance; and professor and vice chair of radiology, University of Washington School of Medicine. The statement...

---

American College of Surgeons Voices Strong Support for American Cancer Society Screening Mammography Guidelines
Encourages women to partner with their physicians to determine when and how often to receive mammograms CHICAGO, Nov. 19 /PRNewswire-USNewswire/ -- The American College of Surgeons (ACoS) today released comments strongly supporting current American Cancer Society ...

---

LCA Releases 5th National Report Card on Lung Cancer
Notes Some Improvements, But Passing Grades Still Lacking WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) released its annual National Report Card on Lung Cancer, an overall assessment of efforts to reduce lung cancer's mortal...

---

Susan G. Komen for the Cure® Recommends No Impediments to Breast Cancer Screening
DALLAS - Susan G. Komen for the Cure®, the world’s leading breast cancer advocacy organization, has carefully reviewed the data and new recommendations from the U.S. Preventive Services Task Force (USPSTF) concerning mammography screening. Komen for the Cure issued the following st

---

CPRIT’s First Round of Requests for Prevention Funding Exceeds Total Budget Amount
AUSTIN, Texas - CPRIT receives requests totaling over $28 million in response to its initial prevention funding opportunities. The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that 55 applications were received in response to CPRIT’s

---

Stephen W. Wyatt, D.M.D, M.P.H., to Head CPRIT Prevention Review Council
AUSTIN, Texas - The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that Stephen W. Wyatt, D.M.D, M.P.H. will chair CPRIT’s prevention review council overseeing the selection of the agency’s prevention grants. Dr. Wyatt has an impressive public health ca

---

CPRIT Responds to USPSTF Revised Mammography Screening Guidelines
AUSTIN, Texas - The Cancer Prevention and Research Institute of Texas (CPRIT) announced today at its quarterly board meeting that it will continue to support mammography screening for women at average risk for breast cancer beginning at age 40. This comes in response to a recent United State

---

Paisley, the Portuguese Water Dog, Will Soon Arrive at maurices
Sales Will Support the American Cancer Society/I/P PDuluth, Minn. (Vocus) November 17, 2009 -- a href= https://secure.maurices.com/chatter/images/HOL_900ePaisley8x6.pdf onclick= linkClick( this.href ); target= _blank title= Paisley, the Portuguese Water Dog Paisley, the Portugues...

---

Biggest NASDAQ Stocks Losers were PARD, CRXX, CHIO : by Penny Stock Pick Alert
(EMAILWIRE.COM, November 17, 2009 ) Dallas, TX - Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) declined 75.86% to close the day at $1.83 on 37.52 million shares after Poniard Pharmaceuticals Inc.'s Picoplatin treatment for small-cell lung cancer didn't..

---

USPSTF Mammography Recommendations Will Result in Countless Unnecessary Breast Cancer Deaths Each Year
RESTON, Va., Nov. 16 /PRNewswire-USNewswire/ -- If cost-cutting U.S. Preventive Services Task Force (USPSTF) mammography recommendations are adopted as policy, two decades of decline in breast cancer mortality could be reversed and countless American women may die needlessly from breast...

---

California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication
LOS ANGELES, Nov. 20 /PRNewswire/ -- California minority advocacy groups including Healthy African American Families, The Wall/Las Memorias, Latina Breast Cancer Agency, Black Barbershop Health Outreach Program, and the Real Medicine Foundation today sent a letter to Bl...

---

Susan G. Komen for the Cure's Nancy Brinker to Grapple with New Guidelines for Breast Cancer Screening, Mon., Nov. 23
WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- Ambassador Nancy G. Brinker, founding chair of Susan G. Komen for the Cure, will address the controversy over new federal breast cancer screening recommendations at a Speakers Newsmakers press conference in the Holeman Lounge at 12:00 p.m. on M...

---

LA County Helps Smokers Quit With Free Nicotine Patches and Gum
LOS ANGELES, CA -- 11/19/09 -- The Los Angeles County Department of Public Health is encouraging residents to quit smoking for at least 24 hours as part of the American Cancer Society's 33rd annual Great American Smokeout. To help smokers with thei..

---

Moffitt Cancer Center Awarded Nearly $19 Million in Recovery Act Grants
TAMPA, Fla., Nov. 19 /PRNewswire/ -- Moffitt Cancer Center has been awarded nearly $19 million in grants from the National Institutes of Health under the

---

Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI)
NEWPORT NEWS, Va., Nov. 19 /PRNewswire/ -- Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) has been recognized and endorsed by two highly esteemed organizations for the fight against breast cancer: The Society of Breast Imaging (SBI) and the American College of...

---

Advocate Lance Armstrong, Scientists Edward E. Harlow, Arnold J. Levine, and Marvin Zelen to Receive American Cancer Society Highest Honor for Outstanding Contributions to Cancer Fight
Society's Medal of Honor to be Awarded on November 19 LOS ANGELES, Nov. 19 /PRNewswire-USNewswire/ -- The American Cancer Society -- the nation's leading voluntary health organization and largest non-governmental investor in cancer research -- will present its high...

---

Love, Set, Taste...Cure! Governors Towne Club Hosts A Most Unique Breast Cancer Fundraiser, Sunday November 22nd, 1 - 4PM
ACWORTH, Ga., Nov. 19 /PRNewswire-USNewswire/ -- A rare blend of events including an afternoon playing tennis paired with a refreshing wine tasting will set the stage for a most unique breast cancer fundraising taking place on Sunday, November 22nd from 1- 4PM in Acworth, Georgia.

---

Med-Vision and Biologics Set to Co-Host a Cancer Management Workshop
TAMPA, Fla. - The healthcare planning team of Med-Vision has partnered with the premier cancer management company, Biologics, Inc., to present a Cancer Management Workshop on Dec. 8 from 8 a.m. to 1 p.m. at the Tampa Club, 101 Kennedy Blvd., Suite 4200, Tampa. Continental

---

Enzon Presents Data at 2009 EORTC Meeting
BRIDGEWATER, N.J. - Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) presented data from its pipeline programs at the 2009 EORTC-NCI-AACR (European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research) annual meeting in Boston, Massac

---

Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
SOUTH SAN FRANCISCO, Calif., Nov. 17 -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). The updated results ind...

---

ImmunoCellular Therapeutics Issues Letter to Shareholders
LOS ANGELES - ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company that is focused on the development of novel immune-based cancer therapies, issued the following Letter to Shareholders today: Dear ImmunoCellular Therapeutics Shareholder:

---

First-of-its-Kind Collaboration Among Advocacy Groups Provides Lung Cancer Patients Personalized Information About Clinical Trials
NEW YORK, Nov. 19 /PRNewswire/ -- Leading patient advocacy organizations announced today that they are teaming up for the first time on an initiative to encourage patients with lung cancer to take charge of their diagnosis and learn about clinical trials, which are an important part of ...

---

AVEO’s Triple VEGF Receptor Inhibitor Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AACR-NCI-EORTC Meeting
CAMBRIDGE, Mass. - AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from a Phase 1 clinical study evaluating its oral, triple VEGF receptor inhibitor tivozanib in combinatio

---

Calistoga Pharmaceuticals Presents Preclinical Data on CAL-120 at The AACR-EORTC-NCI Molecular Targets & Cancer Therapeutics Conference
SEATTLE - Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of results from preclinical studies of CAL-120, a novel

---